Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Shares OutstandingShares Outstanding (Weighted Average)
Others
Receivables - NetReceivables RefundsShares OutstandingShares Outstanding
Ratios

PureTech Health (PRTC) Shares Outstanding (2020 - 2025)

PureTech Health (PRTC) has disclosed Shares Outstanding for 6 consecutive years, with $241.7 million as the latest value for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 0.95% year-over-year to $241.7 million; the TTM value through Dec 2025 reached $241.7 million, up 0.95%, while the annual FY2025 figure was $241.7 million, 0.95% up from the prior year.
  • Shares Outstanding hit $241.7 million in Q4 2025 for PureTech Health, up from $239.4 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $287.8 million in Q4 2021 and bottomed at $239.4 million in Q4 2024.
  • Average Shares Outstanding over 5 years is $263.9 million, with a median of $271.9 million recorded in 2023.
  • Year-over-year, Shares Outstanding decreased 11.93% in 2024 and then grew 0.95% in 2025.
  • PureTech Health's Shares Outstanding stood at $287.8 million in 2021, then dropped by 3.21% to $278.6 million in 2022, then fell by 2.41% to $271.9 million in 2023, then fell by 11.93% to $239.4 million in 2024, then rose by 0.95% to $241.7 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $241.7 million, $239.4 million, and $271.9 million for Q4 2025, Q4 2024, and Q4 2023 respectively.